Ligand Pharmaceuticals Inc (LGND)

Net Receivables

$69.92M

Quarterly · Period ending: · USD

LGND logo

LGND Net Receivables

Latest reported$69.92M
LGND Quarterly Net Receivables ($700.00K → $69.92M)
High-resolution chart · PNG

LGND net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
69,922,000
54,798,000
61,047,000
58,096,000
42,116,000
42,831,000
42,449,000
42,131,000
37,481,000
28,435,000
39,312,000
36,003,000
27,994,000
29,188,000
35,038,000
65,953,000
63,272,000
41,797,000
91,646,000
70,714,000
62,850,000
55,581,000
59,064,000
32,907,000
44,553,000
46,777,000
41,748,000
21,958,000
20,259,000
26,615,000
55,850,000
46,976,000
42,001,000
40,985,000
25,596,000
15,823,000
16,669,000
7,057,000
18,218,000
9,793,000
10,446,000
12,254,000
6,901,000
5,800,000
6,127,000
7,423,000
13,641,000
5,812,000
3,133,000
5,681,000
6,724,000
10,133,000
5,534,000
8,879,000
8,944,000
6,588,000
5,751,000
7,890,000
12,434,000
9,749,000
9,067,000
9,413,000
13,602,000
9,876,000
9,777,000
10,014,000
10,400,000
14,035,000
12,568,000
13,912,000
12,100,000
2,128,000
8,682,000
10,416,000
0
15,377,000
15,017,000
15,659,000
15,587,000
7,077,000
18,667,000
20,046,000
20,954,000
24,378,000
21,016,000
18,324,000
30,847,000
30,583,000
17,936,000
14,185,000
19,051,000
9,923,000
7,689,000
17,086,000
7,356,000
7,001,000
13,498,000
7,569,000
9,798,000
6,434,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.